Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | No references |
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | serine/threonine protein kinase | 0.0114 | 0.0315 | 0.192 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0166 | 0.0609 | 0.3709 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.0297 | 0.0078 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.0609 | 0.0396 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0688 | 0.0477 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.0315 | 0.5 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0111 | 0.0297 | 0.1626 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.0688 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0315 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0114 | 0.0315 | 0.2009 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.0609 | 0.0396 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0315 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.035 | 0.1643 | 0.1453 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0114 | 0.0315 | 0.5 |
Giardia lamblia | Kinase, PLK | 0.0114 | 0.0315 | 1 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.0688 | 0.3283 |
Loa Loa (eye worm) | hypothetical protein | 0.035 | 0.1643 | 0.1453 |
Loa Loa (eye worm) | hypothetical protein | 0.1837 | 1 | 1 |
Brugia malayi | Serotonin/octopamine receptor family protein 7 | 0.035 | 0.1643 | 1 |
Loa Loa (eye worm) | inward rectifying k channel family protein 1 | 0.1837 | 1 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0166 | 0.0609 | 0.8309 |
Schistosoma mansoni | camp-specific 35-cyclic phosphodiesterase | 0.0111 | 0.0297 | 0.1811 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0114 | 0.0315 | 0.066 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.0688 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0688 | 0.0477 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0166 | 0.0609 | 0.8309 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.0688 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0114 | 0.0315 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0315 | 0.5 |
Echinococcus multilocularis | serotonin receptor | 0.0166 | 0.0609 | 0.8309 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0111 | 0.0297 | 0.1626 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0315 | 0.5 |
Schistosoma mansoni | biogenic amine (octopamine/dopamine) receptor | 0.035 | 0.1643 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0315 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.1837 | 1 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0114 | 0.0315 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0315 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.0315 | 0.5 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0114 | 0.0315 | 0.0096 |
Echinococcus granulosus | cAMP specific 3'5' cyclic phosphodiesterase | 0.0111 | 0.0297 | 0.1626 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0114 | 0.0315 | 0.2009 |
Echinococcus multilocularis | cAMP specific 3',5' cyclic phosphodiesterase | 0.0111 | 0.0297 | 0.1626 |
Trypanosoma brucei | polo-like protein kinase | 0.0114 | 0.0315 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1837 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.0315 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (binding) | 0.1413 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.3714 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.